Posted May. 8, 2012 at 5:12 p.m.

Premium Lock Pozen migraine drug licensed to Desitin for commercialization in Europe

Published: 2012-05-08 17:12:10
Updated: 2012-05-08 17:12:10

Print this blog post
Pozen The migraine headache treatment developed by Pozen now has a partner for commercialization in Europe.

The migraine headache treatment developed by Pozen now has a partner for commercialization in Europe....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll